- Therma
Bright Inc.’s proprietary technology has received Class II medical device
status from the U.S. Food and Drug Administration
- The
global market for cosmeceuticals was valued at nearly $47 billion in 2017
and is estimated to see continued growth
- The
company is waiting on regulatory approvals for its thermal therapy
technology, which incorporates the use of cannabis or cannabidiol
Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF), a medical
device technology provider focused on addressing dermatological needs in the
multi-billion-dollar cosmeceutical (the convergence of cosmetic and
pharmaceutical products) industry, offers relief for insect and marine life
bites and stings, which is especially relevant as spring weather patterns
transition into increasingly wet and humid conditions.
The company’s pain-free skin care offerings alleviate pain,
itch and discomfort caused by a myriad of creatures, including bees, wasps,
hornets, mosquitos, black flies and jellyfish. Therma Bright’s products,
devices and treatments are effective and non-invasive, offering both cosmetic
and medicinal or therapeutic benefits. This proprietary technology has received
Class II medical device status from the U.S. Food and Drug Administration.
The global market for cosmeceuticals was valued at nearly
$47 billion in 2017 and is estimated to be worth more than $80 billion by 2023.
The industry is growing at a rate of nearly 9.5 percent, according to a report
published by Mordor Intelligence (http://ibn.fm/8VK8q). Many factors are contributing to this
growth, including a “sustained rise in aging population globally.” As the life
expectancy for both women and men increases, the share of people over 75 using
cosmetics is also on the rise. Women and men are desirous of maintaining a
youthful appearance, and this healthy demand for such cosmetic products has
opened a window for innovation. The industry continues to thrive as a result of
these factors.
Currently, Therma Bright is utilizing social media to market
its products, working to develop and maintain relationships with established
North American and global retailers. In an effort to enter the flourishing
cannabis market, Therma Bright is also researching methods of utilizing medical
grade cannabis or cannabidiol (CBD) to achieve back, knee and other joint pain
relief. Once it obtains the proper regulatory approvals, the company plans to
use its wholly owned subsidiary to produce and sell its thermal therapy
technology, which incorporates medical cannabis.
For more information, visit the company’s website at www.ThermaBright.com
NOTE TO INVESTORS: The latest news and updates
relating to THRBF are available in the company’s newsroom at http://ibn.fm/THRBF
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php

No comments:
Post a Comment